Kilitch Drugs

318.30
+0.90
(0.28%)
Market Cap
511.90
Eps
9.17
PE Ratio (TTM)
31.25
Dividend Yield
0.00
Industry
Healthcare
52 Week High
470.00
52 Week low
300.00
PB Ratio
2.72
Debt to Equity
0.16
Sector
Pharmaceuticals
Add Ratio

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Growth Rate
Revenue Growth
11.51 %
Net Income Growth
63.86 %
Cash Flow Change
-105.79 %
ROE
40.55 %
ROCE
27.94 %
EBITDA Margin (Avg.)
25.47 %

Yearly Financial Results

Annual Financials
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
TTM
Revenue
22
24
30
54
87
57
71
117
143
159
169
Expenses
21
25
29
46
76
53
63
104
122
130
140
EBITDA
1
-2
0
8
11
4
8
13
21
29
28
Operating Profit %
-10 %
-21 %
-2 %
10 %
9 %
0 %
8 %
9 %
13 %
16 %
10 %
Depreciation
2
10
10
2
2
2
2
3
4
3
3
Interest
0
0
0
0
0
1
1
1
5
6
5
Profit Before Tax
-1
-12
-9
6
9
2
5
10
12
19
20
Tax
-1
-0
-0
1
5
1
1
3
4
6
6
Net Profit
-0
-11
-9
5
4
1
4
6
8
14
14
EPS in ₹
-0.22
-8.46
-6.72
3.89
2.61
0.55
2.43
4.73
6.71
9.17
10.30

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
127
117
113
128
144
143
203
210
220
240
Fixed Assets
9
42
33
33
32
32
30
65
64
62
Current Assets
47
47
49
63
65
56
80
114
126
146
Capital Work in Progress
0
0
1
3
20
30
66
3
4
6
Investments
25
23
53
56
53
52
60
71
62
72
Other Assets
93
51
26
35
38
30
47
71
90
100
Total Liabilities
127
117
113
128
144
143
203
210
220
240
Current Liabilities
7
8
12
15
20
22
73
69
69
64
Non Current Liabilities
0
0
0
0
0
0
0
0
0
0
Total Equity
120
109
101
113
123
121
130
140
151
176
Reserve & Surplus
107
96
88
96
106
103
112
121
131
160
Share Capital
13
13
13
14
15
15
16
16
16
16

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
-39
-2
-0
3
3
-5
10
-2
10
-1
Investing Activities
-31
-20
-2
-4
-14
-10
-38
-15
8
-10
Operating Activities
-8
17
1
1
0
5
46
6
3
-0
Financing Activities
-0
0
0
6
17
1
2
7
-1
9

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Promoter
68.63 %
68.33 %
68.33 %
68.25 %
68.25 %
68.25 %
68.25 %
68.25 %
68.25 %
68.25 %
69.23 %
69.23 %
69.23 %
69.23 %
69.23 %
69.23 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
27.65 %
27.41 %
27.67 %
27.28 %
27.58 %
27.73 %
27.60 %
27.52 %
27.49 %
27.40 %
26.13 %
26.13 %
25.37 %
25.21 %
25.10 %
25.74 %
No of Share Holders
9,756
9,214
8,740
9,129
9,133
9,209
9,380
9,435
9,522
9,573
9,002
9,062
9,525
9,620
9,920
10,139

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.5 0.5 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield (%) 0.00 0.00 0.26 0.61 0.00 0.00 0.00 0.00 0.00 0.00
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,752.75 4,20,543.44 35.94 49,887.20 12.06 9,648 13.77 44.79
6,123.50 1,62,559.68 78.25 8,184.00 0.89 1,600 64.53 60.08
1,436.80 1,16,037.99 23.45 26,520.70 14.17 4,155 47.38 46.67
3,114.70 1,05,415.60 56.43 10,785.70 11.59 1,656 13.54 35.94
2,483.00 1,02,440.36 51.56 10,615.60 19.57 1,942 -16.38 42.73
1,227.55 1,02,428.11 18.95 28,905.40 12.36 5,578 1.69 41.25
2,185.10 99,683.73 36.66 20,141.50 19.94 1,936 73.53 56.12
977.00 98,309.06 22.90 19,831.50 13.82 3,831 29.92 51.89
1,191.75 69,217.03 18.82 29,559.20 17.55 3,169 8.66 48.98
5,117.95 61,192.77 28.08 12,978.40 9.84 1,812 14.16 43.89

Corporate Action

Technical Indicators

RSI(14)
Neutral
44.62
ATR(14)
Less Volatile
14.73
STOCH(9,6)
Oversold
12.84
STOCH RSI(14)
Neutral
20.47
MACD(12,26)
Bearish
-1.59
ADX(14)
Weak Trend
18.61
UO(9)
Bearish
33.59
ROC(12)
Downtrend But Slowing Down
-6.30
WillR(14)
Oversold
-88.06